Asadil, Absari U.
HRN: 28-34-19 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/28/2025
01/04/2026
IV
500mg
Q8
Intestinal Amoebiasis
Checking Initial Appropriateness
12/30/2025
AZITHROMYCIN 500MG TABLET (TAB)
12/30/2025
01/06/2026
PO
500mg
OD
CAP-MR
Checking Final Appropriateness